SUN Pharmaceutical Industries Limited — Amlodipine Exporter Profile
Indian Pharmaceutical Exporter · #11 for Amlodipine · $6.8M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #11 Indian exporter of Amlodipine with $6.8M in export value and 135 verified shipments. SUN Pharmaceutical Industries Limited holds a 0.9% market share in Amlodipine exports across 6 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Amlodipine Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Amlodipine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $4.3M | 115 | 83.1% |
| BELGIUM | $539.4K | 41 | 10.4% |
| KENYA | $148.3K | 7 | 2.9% |
| FRANCE | $83.3K | 9 | 1.6% |
| ZIMBABWE | $66.6K | 3 | 1.3% |
| NIGERIA | $26.0K | 3 | 0.5% |
| SOUTH AFRICA | $11.9K | 2 | 0.2% |
| SOMAALIA | $369 | 1 | 0.0% |
SUN Pharmaceutical Industries Limited exports Amlodipine to 8 countries. The largest destination is MYANMAR accounting for 83.1% of SUN Pharmaceutical Industries Limited's Amlodipine shipments, followed by BELGIUM (10.4%) and KENYA (2.9%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amlodipine from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYIT MAHAR TRADING CO., LTD. | MYANMAR | $2.3M | 59 |
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $514.6K | 38 |
| M/S. MYIT MAHAR TRADING CO., LTD. | MYANMAR | $466.3K | 12 |
| MYIT MAHAR TRADING CO., LIMITED | MYANMAR | $419.1K | 13 |
| MYIT MAHAR TRADING CO. LIMITED | MYANMAR | $276.4K | 8 |
| MYIT MAHAR TRADING CO LIMITED | MYANMAR | $232.8K | 6 |
| MYIT MAHAR TRADING CO LTD | MYANMAR | $215.5K | 6 |
| MYIT MAHAR TRADING CO., LTD | MYANMAR | $183.3K | 5 |
| M/S | MYANMAR | $118.4K | 3 |
| M/S. PHARMACEUTICAL & CHEMICAL | ZIMBABWE | $66.6K | 3 |
SUN Pharmaceutical Industries Limited supplies Amlodipine to 23 buyers globally. The largest buyer is MYIT MAHAR TRADING CO., LTD. (MYANMAR), followed by YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and M/S. MYIT MAHAR TRADING CO., LTD. (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amlodipine Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $311.2M worth of Amlodipine through 15,000 shipments from 599 suppliers to 159 countries, serving 1,862 buyers globally. SUN Pharmaceutical Industries Limited contributes $6.8M to this total, accounting for 0.9% of India's Amlodipine exports. SUN Pharmaceutical Industries Limited ships Amlodipine to 8 countries through 23 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Amlodipine Exports?
SUN Pharmaceutical Industries Limited's average Amlodipine shipment value is $50.0K per consignment, based on 135 shipments totaling $6.8M. The largest destination is MYANMAR (83.1% of SUN Pharmaceutical Industries Limited's Amlodipine exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Amlodipine Exporters?
SUN Pharmaceutical Industries Limited ranks #11 among 599 Indian Amlodipine exporters with a 0.9% market share. The top 3 exporters are CIPLA LIMITED ($101.8M), ALKEM LABORATORIES LIMITED ($37.3M), UNICHEM LABORATORIES LIMITED ($34.5M). SUN Pharmaceutical Industries Limited processed 135 shipments to 6 destination countries.
What Amlodipine Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMLOSUN 5 TABLETS ( Amlodipine Tablets, | $700.0K | 14 |
| AMLOSUN 10 TABLETS (Amlodipine Tablets, | $400.7K | 9 |
| AMLOSUN 5 TABLETS ( Amlodipine Tablets,5mg)PACK : 10*10 Batch : JMF0015A, JME1164A, JMF0016A, JMF0017A, JME0951A, JME09 | $150.0K | 3 |
| AMLOSUN 10 TABLETS (AMLODIPINE TABLETS,10MG) SAP CODE : 1136304 BNO. JME0911A,JME0912A,JME0901A MFD.10/23 EXP.09/26 *** | $148.9K | 3 |
| AMLODIPINE TABLETS 5MG ( AMLODIPINA TERAPIA TAB 5MG ) EACH TABLET CONTAINS: AMLODIPINE BESILATE PH.EUR EQ. TO AMLODIPINE | $134.0K | 6 |
| AMLOSUN 5 TABLETS ( Amlodipine Tablets,5mg) | $118.4K | 3 |
| AMLOSUN 5 TABLETS ( AMLODIPINE TABLETS5MG) PACK : 10*10 BATCH : JMF0155A | $88.3K | 3 |
| AMLOSUN 10 TABLETS (AMLODIPINE TABLETS,10MG) BATCH: JME0835A/JME0899A MFD: 20.09.2023/09.10.2023 EXP: 31.08.2026/30.09. | $83.3K | 3 |
| AMLOSUN 5 TABLETS ( AMLODIPINE TABLETS,5MG) PACK : 10*10 BATCH : JME0742A, JME0763A, JME0531BPCS | $82.7K | 3 |
| AMLOSUN 5 TABLETS ( AMLODIPINE TABLETS,5MG)PACK : 10*10 BATCH : JME0952A, JME0763A, JME0742APCS | $75.8K | 3 |
SUN Pharmaceutical Industries Limited exports 107 distinct Amlodipine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMLOSUN 5 TABLETS ( Amlodipine Tablets, with 14 shipments worth $700.0K.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Amlodipine Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | AJANTA PHARMA LIMITED | $12.4M | 375 | 19 | $33.1K |
| 12 | EMCURE PHARMACEUTICALS LIMITED | $7.0M | 468 | 25 | $14.9K |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $6.8M | 135 | 6 | $50.0K |
| 10 | MEDREICH LIMITED | $5.7M | 113 | 4 | $50.0K |
| 13 | ZYDUS LIFESCIENCES LIMITED | $5.6M | 263 | 20 | $21.1K |
SUN Pharmaceutical Industries Limited ranks #11 among 599 Indian Amlodipine exporters. Average shipment value of $50.0K compared to the market average of $519.5K. The closest competitors by value are AJANTA PHARMA LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Amlodipine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 2,082 | 13.9% |
| NHAVA SHEVA SEA (INNSA1) | 1,850 | 12.3% |
| JNPT/ NHAVA SHEVA SEA | 1,599 | 10.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,229 | 8.2% |
| DELHI AIR | 802 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 748 | 5.0% |
| JNPT | 710 | 4.7% |
| Bombay Air | 417 | 2.8% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Amlodipine Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Amlodipine, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amlodipine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amlodipine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 181 individual customs records matching SUN Pharmaceutical Industries Limited exporting Amlodipine, covering 107 formulations to 8 countries via 23 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 159+ countries, 1,862+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amlodipine Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Amlodipine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Amlodipine Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amlodipine. For current shipment-level data, contact TransData Nexus.